Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circumferential strain recovery after human cardiomyocyte transplantation in minipigs using a novel frequency-based method for myocardial tagging quantification.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2026
Same author

Cell-type specific allelic dampening of sex-linked genes in sex chromosome aneuploidy.

bioRxiv : the preprint server for biology·2026
Same author

Nanopatterned Cell Sheet Assembly of Biomimetic Cardiac Laminae for Modeling Structure-Function Relationships.

Biomaterials research·2026
Same author

Clinical and Economic Implications of Cardiac Resynchronization Timing and Longitudinal Medication Titration: A Real-world Medicare Analysis.

Journal of cardiac failure·2026
Same author

Reliable Identification of Cardiac Maturation Markers Using Robust and Flexible Label-Free Proteomic Quantitation by Spectral Counting on Relatively Abundant Proteins.

Journal of proteome research·2026
Same author

Functional interrogation of contextually correct MYH7 variants using CRaTER-flox gene editing and contractility profiling.

The Journal of clinical investigation·2025

Related Experiment Video

Updated: Jun 6, 2026

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Cardiogenesis from human embryonic stem cells.

John L Mignone1, Kareen L Kreutziger, Sharon L Paige

  • 1Department of Pathology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.

Circulation Journal : Official Journal of the Japanese Circulation Society
|November 19, 2010
PubMed
Summary
This summary is machine-generated.

Human embryonic stem cells (ESCs) can be differentiated into cardiomyocytes to repair heart damage. Tissue engineering with vascular networks improves cell survival and cardiac function after transplantation.

More Related Videos

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Related Experiment Videos

Last Updated: Jun 6, 2026

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Human embryonic stem cells (ESCs) offer therapeutic potential for repairing damaged heart tissue.
  • Understanding cardiac development pathways is crucial for cardiovascular differentiation.
  • Key pathways include transforming growth factor-β superfamily and Wnt/β-catenin signaling.

Purpose of the Study:

  • To explore the use of human ESCs for cardiac repair.
  • To investigate methods for generating enriched populations of cardiomyocytes from ESCs.
  • To evaluate strategies for improving the survival and integration of transplanted cardiomyocytes.

Main Methods:

  • Culturing and differentiating human ESCs into cardiomyocytes.
  • Optimizing signaling pathways (e.g., Wnt/β-catenin) for cardiovascular differentiation.
  • Transplantation of cardiomyocytes and engineered cardiac tissue into animal models of heart attack.
  • Assessing graft survival, tissue regeneration, and functional improvement of the heart.
  • Developing pre-organized vascular networks in engineered cardiac tissue.

Main Results:

  • Highly enriched populations of immature cardiomyocytes can be generated from ESCs.
  • Transplanted cardiomyocytes survive and form new myocardial tissue, improving heart function in animal models.
  • Engineered cardiac tissue survival is limited by ischemia, but pre-vascularization enhances survival.
  • Engineered human capillaries can anastomose with the host coronary circulation.

Conclusions:

  • ESC-derived cardiomyocytes show promise for repairing damaged hearts.
  • Tissue engineering strategies, particularly vascularization, are essential for successful cardiac regeneration.
  • Understanding cardiovascular development pathways provides building blocks for heart failure therapies.